Antagonists of IL-17 isoforms and their uses
US9834601B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2013 |
| Grant date | Dec 5, 2017 |
| Priority date | — |
| Expiry date | Jun 11, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antagonists of IL-17 isoforms and their uses in diagnosis and therapy, especially for the treatment or prevention of cancers or autoimmune and chronic inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.